New epigenetic insights are accelerating drug discovery and clinical trials By tracking 5hmC in blood, researchers can capture active cancer pathways, identify novel drug targets, and monitor treatment response more efficiently than traditional approaches.
No hay comentarios:
Publicar un comentario